#Opioids

New Medicaid Policy Will Help States Better Fight the Opioid Crisis

The number of people treated for hepatitis C hit a low point during the COVID-19 pandemic.

Pregnant people at highest risk for hepatitis C were white, American Indian or Alaska Natives and lived in the Northeast or Appalachia.

Jason Skinner got tested for hepatitis C and then got into care and treatment. Those two simple decisions changed his life.

The funding, which also supports harm reduction, arrives from the NY attorney general’s settlements with opioid manufacturers.

The study results, from 2019, precede the surge of overdose deaths during the COVID-19 pandemic.

A $6.6 million grant aims to integrate services for HIV, hepatitis B and C and substance misuse into primary care clinics across the state.

Data from a new study by the National Institutes of Health was published in the American Journal of Public Health.

National Institutes of Health’s Helping to End Addiction Long-term Initiative is finding scientific solutions to address the opioid crisis.

Mobile clinics could be innovative strategy for expanding access to care and providing uninterrupted treatment for people who inject drugs.

This California county had the highest hepatitis C rates in the state, and yet officials have hampered syringe programs.

The death rate spiked right after the COVID-19 pandemic began.

Areas with lower population density have not seen the same slowdown as urban areas.

Researchers found that longer usage of injection drugs was positively linked to hep C testing.

The Centers for Disease Control and Prevention has learned difficult lessons from such outbreaks over the past five years.

People with an opioid use disorder, in particular, had a tenfold higher risk of being diagnosed with COVID-19.

As overdose death rates have risen in this population, life expectancy has increasingly narrowed.